CN105467130A - Kit for quantitative detection of anti-Sm antibody IgG by using magnetic particle chemiluminescence, and preparation method and detection method thereof - Google Patents

Kit for quantitative detection of anti-Sm antibody IgG by using magnetic particle chemiluminescence, and preparation method and detection method thereof Download PDF

Info

Publication number
CN105467130A
CN105467130A CN201510783185.2A CN201510783185A CN105467130A CN 105467130 A CN105467130 A CN 105467130A CN 201510783185 A CN201510783185 A CN 201510783185A CN 105467130 A CN105467130 A CN 105467130A
Authority
CN
China
Prior art keywords
smigg
reagent
add
magneto separate
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510783185.2A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEIJING AVIC SAIWEI BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Original Assignee
BEIJING AVIC SAIWEI BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEIJING AVIC SAIWEI BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd filed Critical BEIJING AVIC SAIWEI BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Priority to CN201510783185.2A priority Critical patent/CN105467130A/en
Publication of CN105467130A publication Critical patent/CN105467130A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326Magnetic particles
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104Lupus erythematosus [SLE]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

The invention relates to the technical field of immunology detection, and particularly relates to a kit for quantitative detection of an anti-Sm antibody IgG by using magnetic particle chemiluminescence, and a preparation method and a detection method thereof. The kit for quantitative detection of the anti-Sm antibody IgG by using magnetic particle chemiluminescence includes an Anti-Sm IgG calibrator, an Anti-Sm IgG reagent No. 1, an Anti-Sm IgG reagent No. 2, an Anti-Sm IgG magnetic separation reagent, an Anti-Sm IgG control material and a cleaning solution. The invention also discloses a preparation method and a detection method of the above kit. Based on the traditional film strip immunoassay and enzyme-linked immunosorbent assay, the detection method increases the sensitivity and linearity range by 3-5 orders of magnitude, achieves the quantitative detection, and has the advantages of high sensitivity and specificity, good accuracy, low cost, simple operation and the objective judgment of results. The method cooperates with an automated chemiluminescence immunoassay analyzer to reach fully automation, and has broad application prospects.

Description

A kind of magnetic microparticle chemiluminescence that uses quantitatively detects kit of anti-Sm antibody IgG and preparation method thereof and detection method
Technical field
The present invention relates to technical field of immunological detection, be specifically related to a kind of magnetic microparticle chemiluminescence that uses and quantitatively detect kit of anti-Sm antibody IgG and preparation method thereof and detection method.
Background technology
Sm is the abbreviation of a patient's name, is diagnosed as in the patients serum of lupus erythematosus at this, have found this antibody first, therefore names.Later a large amount of reports confirms in lupus erythematosus patients serum, there is this kind of antibody, belongs to a class antinuclear antibodies.Main protein antigen in Sm system is B, B ', D, E protein, molecular weight 11 ~ 29kD, also has the protein such as A, A ', B ", C, F, G and 68kD, 150kD in addition.These protein form compound with small nuclear rna s (snRNAs) the i.e. UsnRNAs very abundant containing guanosine.In mammal, find to have 13 kinds of UsnRNAs, i.e. U1 ~ U13snRNAs at least at present.Sm antigen forms micronuclear ribonucleoprotein (U1, U2, U5, U4/U6snRNP) by U1, U2, U5, U4/U6 and above-mentioned protein, and it plays an important role in the conversion of ripe mRNA (mRNA) at heterogeneous nRNA (hnRNA).
Anti-Sm antibody IgG is the specific antibody of systemic loupus erythematosus (SLE), can be used for the diagnosis of SLE together with anti-dsDNA, anti-nucleosome, anti-ribosomal P protein antibody IgG.Anti-Sm antibody can detect in the SLE patient of 5% ~ 40%.Systemic loupus erythematosus (SLE) is the chronic multisystem disease that a kind of incidence of disease is higher, with multiple autoantibodies, is typical autoimmune disease.But up to the present its definite cause of disease and pathogenesis still unclear, this to SLE diagnosis, treatment and prevention progress cause very large obstacle.In patients serum, autoantibody detects the Major Clinical index that oneself becomes SLE laboratory diagnosis.In recent years, in patients serum, the multiple autoantibodies such as anti-ENA antibody, anti-ds-DNA antibody, ANA and anticardiolipin antibody are detected.ENA can be divided into the known and non-principal component totally tens kinds such as Sm, RNP, SSA, SSB, Rib and histone, wherein Sm, RNP and Rib three and SLE in close relations.The anti-Sm antibody positive is considered to the markup antibody of SLE, very at present large to SLE diagnostic significance, uses magnetic microparticle chemiluminescence analytic approach to have not yet to see in the application of anti-Sm antibody IgG immunoassay product.
Chinese patent CN103105489A discloses HP immunoblotting kit detecting autoimmune disease antibody and preparation method thereof, relate to a kind of HP immunoblotting kit detecting various autoimmune disease relevant antibodies, solve and there is no the deficiency in the Western blotting product technology of various autoimmune disease health check-up examination at present: contain on described nitrocellulose filter or nylon membrane: respectively by dsDNA, Sm/RNP, CCP, SSA, SSB, GAD, ICA, IA-2A, TG, natural or the recombinant antigen bag of in totally 10 kinds at least two kinds of AMA-M2 by more than two parallel detection lines, article 1, high concentration quality control band, article 1, middle concentration quality control band and 1 low concentration quality control band.Be a kind of film bar immunization disclosed in this patent, more can illustrate that the sensitivity that film bar immunization exists is lower, the range of linearity is narrow, poor repeatability and reaction time long problem.
Summary of the invention
In order to overcome defect of the prior art, the invention provides a kind of kit using magnetic microparticle chemiluminescence quantitatively to detect anti-Sm antibody IgG, it can prepare with lower cost, and can realize anti-Sm antibody IgG accurately and the quantitative measurement of high precision ground.
The present invention is achieved by the following technical solution: a kind of kit using magnetic microparticle chemiluminescence quantitatively to detect anti-Sm antibody IgG, and described kit comprises: Anti-SmIgG calibration object, No. 1, Anti-SmIgG reagent, No. 2, Anti-SmIgG reagent, Anti-SmIgG Magneto separate reagent, Anti-SmIgG quality-control product and cleaning fluid.
Described Anti-SmIgG calibration object comprises 6 liquid calibration bottles, described liquid calibration bottle internal object concentration is respectively 0,5,20,50,100, the anti-Anti-Sm IgG antibody of 200RU/mL and the Tris damping fluid of bovine serum albumin(BSA);
No. 1, described Anti-SmIgG reagent is 1 bottle containing the biotin labeled Sm antigen of 5mL and the Tris damping fluid of bovine serum albumin(BSA);
No. 2, described Anti-SmIgG reagent is 1 and contains the sheep anti-human polyclonal antibody of alkali phosphatase enzyme mark of 15mL and the bottle of the Tris damping fluid of bovine serum albumin(BSA);
Described Anti-SmIgG Magneto separate reagent is 1 magnetic particle of marked by streptavidin and the Tris damping fluid bottle of bovine serum albumin(BSA) that contain 5mL; Described Anti-SmIgG quality-control product comprises 2 Quality Control bottles, and the scope of the concentration in described Quality Control bottle is respectively: 16-24RU/mL and 80-120RU/mL.
Described kit Cleaning Principle is by testing sample, No. 1, described Anti-SmIgG reagent mixing incubation, anti-Sm antibody IgG in sample is combined with Sm antigentic specificity, add described Anti-SmIgG Magneto separate reagent again, the immune complex of anti-Sm antibody IgG and Sm antigen is adsorbed to magnetic particle surface, unconjugated antibody and impurity are removed in washing, add No. 2, Anti-SmIgG reagent and mix incubation.Goat anti-human igg antibody and the anti-Sm antibody IgG specific binding be combined on magnetic bead of alkali phosphatase enzyme mark (ALP).Washing adds chemical luminous substrate after removing unconjugated antibody and impurity, and ALP catalytic substrate is luminous, measures relative luminous intensity (RLU).In RLU and sample, anti-Sm antibody IgG concentration is proportional within the specific limits, just can be calculated the anti-Sm antibody IgG content of testing sample by RLU from typical curve.
The another technical scheme that the present invention takes is: the preparation method of the magnetic microparticle chemiluminescence immue quantitative detection reagent box of a kind of anti-Sm antibody IgG, and the preparation method of described kit comprises the following steps:
Step 1. is prepared described Anti-SmIgG calibration object and is comprised: Anti-SmIgG calibration object diluent preparing step and Anti-SmIgG calibration object preparation steps:
The preparation steps of described Anti-SmIgG calibration object dilution comprises:
Add the Tris of 800mL purified water and 11.2g in container, be uniformly mixed, add the sodium chloride of 8.5g and the Proclin300 of 2mL again, be stirred to and dissolve completely, pH value is adjusted to 7.0-7.5, add the bovine serum albumin(BSA) of 40g in container, be stirred to and dissolve completely, then pH value is adjusted to 7.0-7.5, be settled to 1L by purified water, use 0.2 μm of frit, by obtain described calibration object dilution be kept at 2-8 DEG C stand-by;
The preparation steps of described Anti-SmIgG calibration object comprises:
With above-mentioned Anti-SmIgG calibration object dilution anti-Sm antibody IgG is formulated as respectively 0,5,20,50,100,200RU/mL totally 6 concentration point;
Step 2. is prepared No. 1, described Anti-SmIgG reagent and is comprised: Anti-SmIgG reagent No. 1 diluent preparing step and Anti-SmIgG reagent No. 1 preparation steps:
The preparation steps of described Anti-SmIgG reagent No. 1 dilution:
Add 800mL purified water, 12.1g the NaCl of Tris and 5.8g in 1L container, be stirred to and dissolve completely, add the Proclin300 of 2mL again, be stirred to and dissolve completely, then add the bovine serum albumin(BSA) of 5g, be stirred to and dissolve completely, pH value is adjusted to 7.0-7.5, be settled to 1L by purified water, use 0.2 μm of frit, by obtain described reagent No. 1 dilution be kept at 2-8 DEG C stand-by;
The preparation steps of No. 1, described Anti-SmIgG reagent:
By the biotin solution of the pH9.0 carbonate buffer solution preparation 0.5mg/mL of 0.2mol/L, the ratio being 10:1 according to Sm antigen and biotin solution mass ratio joins the biotin solution of above-mentioned 0.5mg/mL in Sm antigenic solution, mix, room temperature leaves standstill 18h, reaction generates the reactant liquor of Sm antigen-biotin conjugate, the Sm obtained antigen-biotin conjugate reactant liquor is separated by G-25 gel column, remove unreacted biotin, obtain Sm antigen-biotin conjugate, with described reagent No. 1 dilution, Sm antigen-biotin conjugate is diluted to 0.1-0.3 μ g/mL again, obtain No. 1, described reagent,
Step 3. is prepared No. 2, described Anti-SmIgG reagent and is comprised: the preparation steps of Anti-SmIgG reagent No. 2 diluent preparing steps and No. 2, Anti-SmIgG reagent:
The preparation steps of described Anti-SmIgG reagent No. 2 dilutions:
The NaCl adding 800mL purified water, the 4-hydroxyethyl piperazine second sulphur of 6.06g and 8.5g, in container, is stirred to and dissolves completely, then add the bovine serum albumin(BSA) of 5g, the ZnCl of 0.1g 2, 0.2mL the MgCl of Proclin300 and 0.1g 2, be stirred to and dissolve completely, pH value is adjusted to 7.5-8.0, be settled to 1L by purified water, use 0.2um frit, described reagent No. 2 dilutions obtained are kept at 2-8 DEG C stand-by;
The preparation steps of No. 2, described Anti-SmIgG reagent:
Be 2-imines thiophane solution by the coupling agent of the 10mg/mL of the goat anti-human antibody of 1mg and 2-4 μ L, room temperature leaves standstill 20min, add the glycine solution 10 μ L of 0.1mol/L, room temperature leaves standstill 5min, with G-25 gel column desalination, collect the rear antibody of activation, by activation after antibody be kept at 2-8 DEG C for subsequent use, get the alkaline phosphatase of 1.5mg, add 4-(N-maleimidomethyl) cyclohexane-1-carboxylic acid succinimide ester solution 10-20 μ L of 5mg/mL, room temperature leaves standstill 30min, with G-25 gel column desalination, collect the rear alkaline phosphatase of activation, by activation after alkaline phosphatase be kept at 2-8 DEG C for subsequent use, again the goat anti-human antibody of above-mentioned activation is mixed with the alkaline phosphatase of activation, 12-24h is left standstill under 2-8 DEG C of condition, purify with Supperdex200 gel-purified post, obtain goat anti-human antibody-alkaline phosphatase connector strong solution, be placed in 2-8 DEG C to save backup, by goat anti-human antibody-alkaline phosphatase connector strong solution by described reagent No. 2 diluted to 0.02-0.1 μ g/mL, obtain No. 2, described reagent,
Step 4. is prepared described Anti-SmIgG Magneto separate reagent and is comprised: Anti-SmIgG Magneto separate reagent dilutions preparation steps and Anti-SmIgG Magneto separate preparation of reagents step:
Described Anti-SmIgG Magneto separate reagent dilutions preparation steps:
Add 800mL purified water, 12.1g the NaCl of Tris and 8.5g in container, be stirred to and dissolve completely, add the Proclin300 of the bovine serum albumin(BSA) of 5g, the NBCS of 50mL and 0.2mL again, be stirred to and dissolve completely, pH value is adjusted to 7.9-8.1, be settled to 1L by purified water, use 0.2um frit, the described Magneto separate reagent dilutions obtained is kept at 2-8 DEG C stand-by;
Described Anti-SmIgG Magneto separate preparation of reagents step:
Get 100mg magnetic particle, Magneto separate removes supernatant, the pH value of taking 0.025mol/L is that the MES damping fluid 10mL of 4.5-6 is resuspended, 2 ~ 3h is mixed under room temperature, adding the concentration that 0.5-1.0mL newly prepares is the carbodiimide of 10mg/mL and the MES damping fluid of N-hydroxy thiosuccinimide, shaken at room temperature suspendible 30-60min, magnetic bead is fully activated, Magneto separate, remove supernatant, be that the MES damping fluid 10mL of 4.5-6 is resuspended by the pH value of 0.025mol/L, add the Streptavidin of 4-8mg, room temperature suspendible 16-20h, carry out Magneto separate again, remove supernatant, with the bovine serum albumin(BSA) of percent concentration 0.5%, the MES damping fluid 10mL of percent concentration 0.5% skimmed milk power and percent concentration 0.05% Tween-20 is resuspended, 2 ~ 3h is mixed under room temperature condition, Magneto separate again, remove supernatant, 0.5mg/mL is resuspended to the dilution of magnetic particle damping fluid, 16 ~ 24h is balanced at 2 ~ 8 DEG C, after mixing 2 ~ 3h under room temperature condition, sonic oscillation instrument is used to be dispersed into individual particle state by assembling agglomerating magnetic bead in suspension, obtain described Anti-SmIgG Magneto separate reagent.
Further, the present invention also provides the preparation process of described cleaning:
Add 800mL purified water, 12.1g the NaCl of Tris and 8.5g in 1L container, be stirred to and dissolve completely, add the Tween-20 of 5g and the Triton100 of 5g again, stir, until mix completely, pH value is adjusted to 7.5-8.0, constant volume 1L, use 0.2 μm of frit, by obtain described cleaning fluid be kept at 2-8 DEG C stand-by, use before by described cleaning fluid according to every 7.5mL add purified water to 100mL dilution proportion and mixing after re-use.
Present invention also offers a kind of detection method using magnetic microparticle chemiluminescence quantitatively to detect the kit of anti-Sm antibody IgG, the detection method of described kit comprises the following steps:
Anti-SmIgG calibration object is put in Full-automatic chemiluminescence immunoassay analysis meter reagent cabin by step 1., obtains the matched curve exported by Full-automatic chemiluminescence immunoassay analysis meter;
Anti-SmIgG quality-control product is put into above-mentioned analyser test position by step 2., obtains the test luminous value of the described quality-control product exported by Full-automatic chemiluminescence immunoassay analysis meter and is obtained the concentration value of Anti-SmIgG quality-control product by the matched curve matching that step 1 obtains;
Testing sample is put into above-mentioned analyser test position by step 3., automatically presses 1:20 by Sample Dilution, obtain the concentration value of the testing sample exported by Full-automatic chemiluminescence immunoassay analysis meter by described analyser.
Further, the invention provides described a kind of detection method using magnetic microparticle chemiluminescence quantitatively to detect the kit of anti-Sm antibody IgG, described step 1, step 2 and step 3 include the fully-automated synthesis step of Full-automatic chemiluminescence immunoassay analysis meter:
Step 1) add the sample to be measured after 20 μ L calibration objects or quality-control product or 1:20 dilution in detector tube;
Step 2) add No. 1, the Anti-SmIgG reagent of 50 μ L to step 1) in described detector tube, after mixing, 37 ± 0.5 DEG C of incubation 10min;
Step 3) add the Anti-SmIgG Magneto separate reagent of 50 μ L to step 2) in described detector tube, after mixing, 37 ± 0.5 DEG C of incubation 5min, carry out Magneto separate, remove supernatant;
Step 4) add the cleaning fluid of 300 μ L in detector tube, mixing, carries out Magneto separate and removes supernatant;
Step 5) repeat step 4) twice;
Step 6) add No. 2,150 μ LAnti-SmIgG reagent in detector tube, after mixing, 37 ± 0.5 DEG C of incubation 10min, carry out Magneto separate and remove supernatant;
Step 7) add the cleaning fluid of 300 μ L in detector tube, mixing, carries out Magneto separate and removes supernatant;
Step 8) repeat step 7) twice;
Step 9) add the chemical luminous substrate of 200 μ L in detector tube, mixing, detect luminous intensity.
Compared with prior art, superior effect is:
No. 1, the Anti-SmIgG reagent 1, in described kit, No. 2, Anti-SmIgG reagent, Anti-SmIgG Magneto separate reagent are the more excellent formulas under this reaction system, provide powerful guarantee to the use of this kit effect phase and detection perform;
2, the Anti-SmIgG Magneto separate reagent participation reaction time in described kit is only 5 minutes, can avoid non-specific adsorption to limits;
3, the Anti-SmIgG Magneto separate reagent in described kit is the super paramagnetic microsphere of polymolecularity, ensures magnetic
Particulate can not be assembled completely in preservation and use procedure;
Alkaline phosphatase in No. 2, the Anti-SmIgG reagent 4, in described kit can catalytic luminescence substrate luminous, and namely reach luminescence-producing reaction plateau, and the light signal of held stationary in 5 seconds, ensure high measurement accuracy and efficiency.
No. 2, the Anti-SmIgG reagent 5, in described kit is the sheep anti-human polyclonal antibody of alkali phosphatase enzyme mark, and the use of sheep anti-human polyclonal antibody, reduces the cost of kit;
6, this kit successfully avoids the no cross reaction with human serum albumins;
7, the sample requirement to be measured in described kit is 20 μ L samples after 1:20 doubly dilutes, and reduces the cost of kit;
8, described detection method is on the basis of traditional film bar immunization and enzyme linked immunosorbent assay, by sensitivity and linear measurement range improving 3-5 the order of magnitude, realizing the quantitative detection of real meaning, has the features such as highly sensitive, high specificity, accuracy are good;
9, described detection method coordinates Full-automatic chemiluminescence immunoassay analysis meter to realize full-automatic use, and easy and simple to handle, result judges the advantages such as objective, has important value for clinical diagnosis, has a extensive future.
Accompanying drawing explanation
Fig. 1 is that in the blank limit evaluation test of the kit of anti-Sm antibody IgG of the present invention, A, B point connects some matched curve schematic diagram;
Fig. 2 is the curve map that the kit range of linearity of anti-Sm antibody IgG of the present invention is evaluated;
Fig. 3 is the magnetic microparticle chemiluminescence quantitative measurement Virus monitory result of kit of the present invention and the relativity evaluation of commercial anti-Sm antibody IgG detection kit enzyme linked immunosorbent assay testing result;
Horizontal ordinate x in Fig. 3 is the kit sample measured value of control methods, and concentration unit is RU/mL, and ordinate y is described kit sample measured value, and concentration unit is RU/mL.
Embodiment
Embodiment 1
Use magnetic microparticle chemiluminescence quantitatively to detect a kit of anti-Sm antibody IgG, this kit comprises: Anti-SmIgG calibration object, No. 1, Anti-SmIgG reagent, No. 2, Anti-SmIgG reagent, Anti-SmIgG Magneto separate reagent, Anti-SmIgG quality-control product and cleaning fluid.
The analytical performance evaluation of kit of the present invention:
1) accuracy estimating
Concentration is about 200RU/mL, allow its concentration deviation be ± 20% anti-Sm antibody IgG sample A join in blood serum sample B liquid, add A volume be no more than 10% of cumulative volume A+B, recovery R is calculated according to formula (1), the recovery of this method is within the scope of 85-115%, and data are see table 1.
R = C × ( V 0 + V ) - C 0 × V 0 V × C S × 100 % ...... ( 1 )
R: the recovery;
The volume of V: sample A liquid;
V 0: the volume of sample B liquid;
C: sample B liquid adds the detectable concentration after A liquid;
C 0: the concentration measuring B liquid;
The concentration of Cs: sample A liquid.
Table 1-accuracy estimating-interpolation recovery experiment data
2) blank limit is evaluated
Detect as sample with zero-dose calibration object, replication 20 times, draw the RLU of 20 measurement results, RLU is relative light unit, calculates its mean value M and standard deviation SD, draws the RLU value corresponding to M+2SD, carry out 2 regression fits according to the result of the concentration-RLU value between zero-dose calibration object and adjacent calibration object and draw linear function, RLU value corresponding to M+2SD is brought in above-mentioned equation, obtains corresponding concentration value, be blank limit.The blank limit of this method is not more than 1RU/mL.Concrete data are see table 2, and A, B point connects some matched curve as shown in Figure 1.
Table 2 blank limit is evaluated
3) range of linearity evaluation
Dilute at least 5 kinds of concentration by a certain percentage by the high level sample close to the range of linearity upper limit being 200RU/mL, wherein the sample of low value concentration must close to the lower limit of the range of linearity.Operate by kit instructions, to the equal duplicate detection of the sample of each concentration 2 times, calculate its mean value, result mean value and dilution ratio least square method are carried out fitting a straight line, and calculate linearly dependent coefficient r, the measurement range of this method is 2 ~ 200RU/mL, and correlation coefficient r answers >=0.9900.Data are see table 3.Curve is shown in Fig. 2.
The evaluation of table 3 range of linearity
4) reproducibility
The kit duplicate detection concentration of getting in the present embodiment is each 10 times of the sample of 20 ± 4RU/mL and 100 ± 20RU/mL, calculate mean value M and the standard deviation SD of 10 measurement results, draw coefficient of variation CV according to formula CV=SD/M × 100%, this method coefficient of variation (CV) is not more than 8%.Data are see table 4.
CV=SD/M×100%......(2)
In formula: CV-coefficient of variation; The standard deviation of SD-10 time measurement result; The mean value of M-10 time measurement result.
Table 4 reproducibility
Measure serum-concentration (RU/mL) Measure number of times CV (%) between analysis
20 10 6.66%
100 10 6.40%
5) difference between batch evaluation
The kit of embodiment is got three batches, often criticize kit and all measure the sample of concentration within the scope of 20 ± 4RU/mL and 100 ± 20RU/mL, often criticize replication 10 times, calculate mean value (M) and the standard deviation (SD) of 30 measurement results, calculate the coefficient of variation (CV) according to formula (3), this method coefficient of variation (CV) is not more than 15%.Data are see table 5.
CV=SD/M×100%......(3)
In formula: CV-coefficient of variation; The standard deviation of SD-30 time measurement result; The mean value of M-30 time measurement result.
The evaluation of table 5 difference between batch
Measure serum-concentration (RU/mL) Measure number of times CV (%) between analysis
20 30 6.89%
100 30 5.25%
6) Evaluation on specificity
Getting 1 part of Anti-SmIgG levels is the sample of 0RU/mL, adds human serum albumins, makes human serum albumins concentration in sample be 5000ng/mL, uses this kit to detect this sample, the Anti-SmIgG content in working sample.The results are shown in Table 6, this method and human serum albumins no cross reaction.Data are see table 6.
Table 6 specificity experiments
Test cross reaction thing Concentration (ng/mL) RLU Measurement result (RU/mL)
Human serum albumins 5000 2468 <1
7) relativity evaluation
By the kit of embodiment and commercial anti-Sm antibody IgG detection kit enzyme linked immunosorbent assay, 240 parts of human serum samples are detected simultaneously.As shown in Figure 3, with the result of anti-Sm antibody IgG detection kit enzyme-linked immunosorbent assay for horizontal ordinate, the result of mensuration is in the process of the present invention that ordinate does regretional analysis to its testing result, and dependent equation is y=0.9986x-0.2855, and related coefficient is R 2: 0.9843.Show through statistical procedures result, this method is good with the kit clinical sample measured value correlativity of additive method.
8) estimation of stability
Get described kit respectively at 4 DEG C 12 months and at 37 DEG C 7 days carry out stability experiment, result show the accuracy of kit standard product, blank limit, linear, repeatability and quality-control product the index such as assignment validity all within normal range, the kit term of validity can reach 12 months.Data are in table 7 and table 8.
Table 7 kit 4 DEG C of stability experiments
Table 8 kit 37 DEG C of stability experiments
Embodiment 2
A kind of preparation method using magnetic microparticle chemiluminescence quantitatively to detect the kit of anti-Sm antibody IgG comprises the following steps:
Step 1. is prepared described Anti-SmIgG calibration object and is comprised: Anti-SmIgG calibration object diluent preparing step and Anti-SmIgG calibration object preparation steps:
The preparation steps of described Anti-SmIgG calibration object dilution comprises:
Add the Tris of 800mL purified water and 11.2g in container, be uniformly mixed, add the sodium chloride of 8.5g and the Proclin300 of 2mL again, be stirred to and dissolve completely, pH value is adjusted to 7.0-7.5, add the bovine serum albumin(BSA) of 40g in container, be stirred to and dissolve completely, then pH value is adjusted to 7.0-7.5, be settled to 1L by purified water, use 0.2 μm of frit, by obtain described calibration object dilution be kept at 2-8 DEG C stand-by;
The preparation steps of described Anti-SmIgG calibration object comprises:
With above-mentioned Anti-SmIgG calibration object dilution anti-Sm antibody IgG is formulated as respectively 0,5,20,50,100,200RU/mL totally 6 concentration point;
Step 2. is prepared No. 1, described Anti-SmIgG reagent and is comprised: Anti-SmIgG reagent No. 1 diluent preparing step and Anti-SmIgG reagent No. 1 preparation steps:
The preparation steps of described Anti-SmIgG reagent No. 1 dilution:
Add 800mL purified water, 12.1g the NaCl of Tris and 5.8g in 1L container, be stirred to and dissolve completely, add the Proclin300 of 2mL again, be stirred to and dissolve completely, then add the bovine serum albumin(BSA) of 5g, be stirred to and dissolve completely, pH value is adjusted to 7.0-7.5, be settled to 1L by purified water, use 0.2 μm of frit, by obtain described reagent No. 1 dilution be kept at 2-8 DEG C stand-by;
The preparation steps of No. 1, described Anti-SmIgG reagent:
By the biotin solution of the pH9.0 carbonate buffer solution preparation 0.5mg/mL of 0.2mol/L, the ratio being 10:1 according to Sm antigen and biotin solution mass ratio joins the biotin solution of above-mentioned 0.5mg/mL in SM antigenic solution, mix, room temperature leaves standstill 18h, reaction generates the reactant liquor of Sm antigen-biotin conjugate, the Sm obtained antigen-biotin conjugate reactant liquor is separated by G-25 gel column, remove unreacted biotin, obtain Sm antigen-biotin conjugate, with described reagent No. 1 dilution, Sm antigen-biotin conjugate is diluted to 0.1-0.3 μ g/mL again, obtain No. 1, described reagent,
Step 3. is prepared No. 2, described Anti-SmIgG reagent and is comprised: the preparation steps of Anti-SmIgG reagent No. 2 diluent preparing steps and No. 2, Anti-SmIgG reagent:
The preparation steps of described Anti-SmIgG reagent No. 2 dilutions:
The NaCl adding 800mL purified water, the 4-hydroxyethyl piperazine second sulphur of 6.06g and 8.5g, in container, is stirred to and dissolves completely, then add the bovine serum albumin(BSA) of 5g, the ZnCl of 0.1g 2, 0.2mL the MgCl of Proclin300 and 0.1g 2, be stirred to and dissolve completely, pH value is adjusted to 7.5-8.0, be settled to 1L by purified water, use 0.2um frit, described reagent No. 2 dilutions obtained are kept at 2-8 DEG C stand-by;
The preparation steps of No. 2, described Anti-SmIgG reagent:
Be 2-imines thiophane solution by the coupling agent of the 10mg/mL of the goat anti-human antibody of 1mg and 2-4 μ L, room temperature leaves standstill 20min, add the glycine solution 10 μ L of 0.1mol/L, room temperature leaves standstill 5min, with G-25 gel column desalination, collect the rear antibody of activation, by activation after antibody be kept at 2-8 DEG C for subsequent use, get the alkaline phosphatase enzyme solutions of 1.5mg, add 4-(N-maleimidomethyl) cyclohexane-1-carboxylic acid succinimide ester solution 10-20 μ L of 5mg/mL, room temperature leaves standstill 30min, with G-25 gel column desalination, collect the rear alkaline phosphatase of activation, by activation after alkaline phosphatase be kept at 2-8 DEG C for subsequent use, again the goat anti-human antibody of above-mentioned activation is mixed with the alkaline phosphatase of activation, 12-24h is left standstill under 2-8 DEG C of condition, purify with Supperdex200 gel-purified post, obtain goat anti-human antibody-alkaline phosphatase connector strong solution, be placed in 2-8 DEG C to save backup, by goat anti-human antibody-alkaline phosphatase connector strong solution by described reagent No. 2 diluted to 0.02-0.1 μ g/mL, obtain No. 2, described reagent,
Step 4. is prepared described Anti-SmIgG Magneto separate reagent and is comprised: Anti-SmIgG Magneto separate reagent dilutions preparation steps and Anti-SmIgG Magneto separate preparation of reagents step:
Described Anti-SmIgG Magneto separate reagent dilutions preparation steps:
Add 800mL purified water, 12.1g the NaCl of Tris and 8.5g in container, be stirred to and dissolve completely, add the Proclin300 of the bovine serum albumin(BSA) of 5g, the NBCS of 50mL and 0.2mL again, be stirred to and dissolve completely, pH value is adjusted to 7.9-8.1, be settled to 1L by purified water, use 0.2um frit, the described Magneto separate reagent dilutions obtained is kept at 2-8 DEG C stand-by;
Described Anti-SmIgG Magneto separate preparation of reagents step:
Get 100mg magnetic particle, Magneto separate removes supernatant, the pH value of taking 0.025mol/L is that the MES damping fluid 10mL of 4.5-6 is resuspended, 2 ~ 3h is mixed under room temperature, adding the concentration that 0.5-1.0mL newly prepares is the carbodiimide of 10mg/mL and the morpholino b acid damping fluid of N-hydroxy thiosuccinimide, shaken at room temperature suspendible 30-60min, magnetic bead is fully activated, Magneto separate, remove supernatant, be that the MES damping fluid 10mL of 4.5-6 is resuspended by the pH value of 0.025mol/L, add the Streptavidin of 4-8mg, room temperature suspendible 16-20h, carry out Magneto separate again, remove supernatant, with the bovine serum albumin(BSA) of percent concentration 0.5%, the MES damping fluid 10mL of percent concentration 0.5% skimmed milk power and percent concentration 0.05% Tween-20 is resuspended, 2 ~ 3h is mixed under room temperature condition, Magneto separate again, remove supernatant, 0.5mg/mL is resuspended to the dilution of magnetic particle damping fluid, 16 ~ 24h is balanced at 2 ~ 8 DEG C, after mixing 2 ~ 3h under room temperature condition, sonic oscillation instrument is used to be dispersed into individual particle state by assembling agglomerating magnetic bead in suspension, obtain described Anti-SmIgG Magneto separate reagent.
Embodiment 3
On the basis of embodiment 2, described kit also comprises cleaning fluid, the preparation process of described cleaning fluid:
Add 800mL purified water, 12.1g the NaCl of Tris and 8.5g in 1L container, be stirred well to and dissolve completely; Add the Tween-20 of 5g and the Triton100 of 5g again, fully stir, until mix completely, adjust pH controls at 7.5-8.0, constant volume 1L, and with 0.2 μm of metre filter, temperature is that 2-8 DEG C of scope is preserved.
Embodiment 4
Described kit is adopted to be applied to the detection method of a kind of anti-Sm antibody IgG, the detecting step comprised:
1) by the Anti-SmIgG-R1 in kit, Anti-SmIgG-R2, Anti-SmIgG-M tri-components are positioned in the Full-automatic chemiluminescence immunoassay analysis meter reagent cabin of our company's development;
2) on instrument software, carry out calibration curve, Anti-SmIgG calibration object is put into instrument test position, obtain exporting matched curve by Full-automatic chemiluminescence immunoassay analysis meter;
3) if instrument prompting matching is passed through, then on instrument software, carry out quality-control product test application, Anti-SmIgG quality-control product is put into instrument assigned address.Obtain exporting by Full-automatic chemiluminescence immunoassay analysis meter the concentration value of quality-control product that quality-control product tested luminous value and obtained by standard curve fit.
4) if Quality Control measured value is in preset range, carry out sample test application, sample is put into instrument test position, the concentration value being exported sample test luminous value by Full-automatic chemiluminescence immunoassay analysis meter and obtained by standard curve fit.
5) Full-automatic chemiluminescence immunoassay analysis meter detecting step is as follows:
Step 1) add the sample to be measured after 20 μ L calibration objects or quality-control product or 1:20 dilution in detector tube;
Step 2) add No. 1,50 μ LAnti-SmIgG reagent to step 1) in described detector tube, after mixing, 37 ± 0.5 DEG C of incubations 10 minutes;
Step 3) add the Anti-SmIgG Magneto separate reagent of 50 μ L to step 2) in described detector tube, after mixing, 37 ± 0.5 DEG C of incubations 5 minutes; Carry out Magneto separate, remove supernatant;
Step 4) add 300 μ L cleaning fluids in detector tube, mixing; Carry out Magneto separate, remove supernatant;
Step 5) repeat step 4) twice;
Step 6) add No. 2,150 μ LAnti-SmIgG reagent in detector tube, after mixing, 37 ± 0.5 DEG C of incubations 10 minutes; Carry out Magneto separate, remove supernatant;
Step 7) add the cleaning fluid of 300 μ L in detector tube, mixing, carries out Magneto separate, removes supernatant;
Step 8) repeat step 7) twice;
Step 9) add 200 μ L chemical luminous substrates in detector tube, mixing, detect luminous intensity.
Above-described embodiment is only for illustrating technical conceive of the present invention and feature; its object is to person skilled in the art can be understood content of the present invention and implement according to this; can not limit the scope of the invention with this; all equivalences done according to Spirit Essence of the present invention change or modify, and all should be encompassed within protection scope of the present invention.

Claims (5)

1. the kit using magnetic microparticle chemiluminescence quantitatively to detect anti-Sm antibody IgG; described kit comprises: Anti-SmIgG calibration object, No. 1, Anti-SmIgG reagent, No. 2, Anti-SmIgG reagent, Anti-SmIgG Magneto separate reagent, Anti-SmIgG quality-control product and cleaning fluid, is characterized in that:
Described Anti-SmIgG calibration object comprises 6 liquid calibration bottles, described liquid calibration bottle internal object concentration is respectively 0,5,20,50,100, the anti-Anti-Sm IgG antibody of 200RU/mL and the Tris damping fluid of bovine serum albumin(BSA);
No. 1, described Anti-SmIgG reagent is 1 bottle containing the biotin labeled Sm antigen of 5mL and the Tris damping fluid of bovine serum albumin(BSA);
No. 2, described Anti-SmIgG reagent is 1 and contains the sheep anti-human polyclonal antibody of alkali phosphatase enzyme mark of 15mL and the bottle of the Tris damping fluid of bovine serum albumin(BSA);
Described Anti-SmIgG Magneto separate reagent be 1 containing 5mL containing the magnetic particle of marked by streptavidin and the Tris damping fluid bottle of bovine serum albumin(BSA);
Described Anti-SmIgG quality-control product comprises the Quality Control bottle of 2, and the scope of the concentration in described Quality Control bottle is respectively: 16-24RU/mL and 80-120RU/mL.
2. use magnetic microparticle chemiluminescence quantitatively to detect a preparation method for the kit of anti-Sm antibody IgG, it is characterized in that, described preparation method comprises:
Step 1. is prepared described Anti-SmIgG calibration object and is comprised: Anti-SmIgG calibration object diluent preparing step and Anti-SmIgG calibration object preparation steps:
The preparation steps of described Anti-SmIgG calibration object dilution comprises:
Add the Tris of 800mL purified water and 11.2g in container, be uniformly mixed, add the sodium chloride of 8.5g and the Proclin300 of 2mL again, be stirred to and dissolve completely, pH value is adjusted to 7.0-7.5, add the bovine serum albumin(BSA) of 40g in container, be stirred to and dissolve completely, then pH value is adjusted to 7.0-7.5, be settled to 1L by purified water, use 0.2 μm of frit, by obtain described calibration object dilution be kept at 2-8 DEG C stand-by;
The preparation steps of described Anti-SmIgG calibration object comprises:
With above-mentioned Anti-SmIgG calibration object dilution anti-Sm antibody IgG is formulated as respectively 0,5,20,50,100,200RU/mL totally 6 concentration point;
Step 2. is prepared No. 1, described Anti-SmIgG reagent and is comprised: Anti-SmIgG reagent No. 1 diluent preparing step and Anti-SmIgG reagent No. 1 preparation steps:
The preparation steps of described Anti-SmIgG reagent No. 1 dilution:
Add 800mL purified water, 12.1g the NaCl of Tris and 5.8g in 1L container, be stirred to and dissolve completely, add the Proclin300 of 2mL again, be stirred to and dissolve completely, then add the bovine serum albumin(BSA) of 5g, be stirred to and dissolve completely, pH value is adjusted to 7.0-7.5, be settled to 1L by purified water, use 0.2 μm of frit, by obtain described reagent No. 1 dilution be kept at 2-8 DEG C stand-by;
The preparation steps of No. 1, described Anti-SmIgG reagent:
By the biotin solution of the pH9.0 carbonate buffer solution preparation 0.5mg/mL of 0.2mol/L, the ratio being 10:1 according to Sm antigen and biotin solution mass ratio joins the biotin solution of above-mentioned 0.5mg/mL in Sm antigenic solution, mix, room temperature leaves standstill 18h, reaction generates the reactant liquor of Sm antigen-biotin conjugate, the Sm obtained antigen-biotin conjugate reactant liquor is separated by G-25 gel column, remove unreacted biotin, obtain Sm antigen-biotin conjugate, with described reagent No. 1 dilution, Sm antigen-biotin conjugate is diluted to 0.1-0.3 μ g/mL again, obtain No. 1, described reagent,
Step 3. is prepared No. 2, described Anti-SmIgG reagent and is comprised: the preparation steps of Anti-SmIgG reagent No. 2 diluent preparing steps and No. 2, Anti-SmIgG reagent:
The preparation steps of described Anti-SmIgG reagent No. 2 dilutions:
The NaCl adding 800mL purified water, the 4-hydroxyethyl piperazine second sulphur of 6.06g and 8.5g, in container, is stirred to and dissolves completely, then add the bovine serum albumin(BSA) of 5g, the ZnCl of 0.1g 2, 0.2mL the MgCl of Proclin300 and 0.1g 2, be stirred to and dissolve completely, pH value is adjusted to 7.5-8.0, be settled to 1L by purified water, use 0.2um frit, described reagent No. 2 dilutions obtained are kept at 2-8 DEG C stand-by;
The preparation steps of No. 2, described Anti-SmIgG reagent:
Be 2-imines thiophane solution by the coupling agent of the 10mg/mL of the goat anti-human antibody of 1mg and 2-4 μ L, room temperature leaves standstill 20min, add the glycine solution 10 μ L of 0.1mol/L, room temperature leaves standstill 5min, with G-25 gel column desalination, collect the rear antibody of activation, by activation after antibody be kept at 2-8 DEG C for subsequent use, get the alkaline phosphatase of 1.5mg, add 4-(N-maleimidomethyl) cyclohexane-1-carboxylic acid succinimide ester solution 10-20 μ L of 5mg/mL, room temperature leaves standstill 30min, with G-25 gel column desalination, collect the rear alkaline phosphatase of activation, by activation after alkaline phosphatase be kept at 2-8 DEG C for subsequent use, again the goat anti-human antibody of above-mentioned activation is mixed with the alkaline phosphatase of activation, 12-24h is left standstill under 2-8 DEG C of condition, purify with Supperdex200 gel-purified post, obtain goat anti-human antibody-alkaline phosphatase connector strong solution, be placed in 2-8 DEG C to save backup, by goat anti-human antibody-alkaline phosphatase connector strong solution by described reagent No. 2 diluted to 0.02-0.1 μ g/mL, obtain No. 2, described reagent,
Step 4. is prepared described Anti-SmIgG Magneto separate reagent and is comprised: Anti-SmIgG Magneto separate reagent dilutions preparation steps and Anti-SmIgG Magneto separate preparation of reagents step:
Described Anti-SmIgG Magneto separate reagent dilutions preparation steps:
Add 800mL purified water, 12.1g the NaCl of Tris and 8.5g in container, be stirred to and dissolve completely, add the Proclin300 of the bovine serum albumin(BSA) of 5g, the NBCS of 50mL and 0.2mL again, be stirred to and dissolve completely, pH value is adjusted to 7.9-8.1, be settled to 1L by purified water, use 0.2um frit, the described Magneto separate reagent dilutions obtained is kept at 2-8 DEG C stand-by;
Described Anti-SmIgG Magneto separate preparation of reagents step:
Get 100mg magnetic particle, Magneto separate removes supernatant, the pH value of taking 0.025mol/L is that the MES damping fluid 10mL of 4.5-6 is resuspended, 2 ~ 3h is mixed under room temperature, adding the concentration that 0.5-1.0mL newly prepares is the carbodiimide of 10mg/mL and the MES damping fluid of N-hydroxy thiosuccinimide, shaken at room temperature suspendible 30-60min, magnetic bead is fully activated, Magneto separate, remove supernatant, be that the MES damping fluid 10mL of 4.5-6 is resuspended by the pH value of 0.025mol/L, add the Streptavidin of 4-8mg, room temperature suspendible 16-20h, carry out Magneto separate again, remove supernatant, with the bovine serum albumin(BSA) of percent concentration 0.5%, the MES damping fluid 10mL of percent concentration 0.5% skimmed milk power and percent concentration 0.05% Tween-20 is resuspended, 2 ~ 3h is mixed under room temperature condition, Magneto separate again, remove supernatant, 0.5mg/mL is resuspended to the dilution of magnetic particle damping fluid, 16 ~ 24h is balanced at 2 ~ 8 DEG C, after mixing 2 ~ 3h under room temperature condition, sonic oscillation instrument is used to be dispersed into individual particle state by assembling agglomerating magnetic bead in suspension, obtain described Anti-SmIgG Magneto separate reagent.
3. a kind of preparation method using magnetic microparticle chemiluminescence quantitatively to detect the kit of anti-Sm antibody IgG according to claim 2, it is characterized in that, described preparation method comprises the preparation process of cleaning fluid:
Add 800mL purified water, 12.1g the NaCl of Tris and 8.5g in 1L container, be stirred to and dissolve completely, add the Tween-20 of 5g and the Triton100 of 5g again, stir, until mix completely, pH value is adjusted to 7.5-8.0, constant volume 1L, use 0.2 μm of frit, by obtain described cleaning fluid be kept at 2-8 DEG C stand-by, use before by described cleaning fluid according to every 7.5mL add purified water to 100mL dilution proportion and mixing after re-use.
4. use magnetic microparticle chemiluminescence quantitatively to detect a detection method for the kit of anti-Sm antibody IgG, comprise the following steps:
Anti-SmIgG calibration object is put into Full-automatic chemiluminescence immunoassay analysis meter test position by step 1., obtains the matched curve exported by Full-automatic chemiluminescence immunoassay analysis meter;
Anti-SmIgG quality-control product is put into above-mentioned analyser test position by step 2., obtains the test luminous value of the described quality-control product exported by Full-automatic chemiluminescence immunoassay analysis meter and is obtained the concentration value of Anti-SmIgG quality-control product by the matched curve matching that step 1 obtains;
Sample to be tested is put into above-mentioned analyser test position by step 3., automatically presses 1:20 by Sample Dilution, obtain the concentration value of the sample to be tested exported by Full-automatic chemiluminescence immunoassay analysis meter by described analyser.
5. a kind of detection method using magnetic microparticle chemiluminescence quantitatively to detect the kit of anti-Sm antibody IgG according to claim 4, is characterized in that: described step 1, step 2 and step 3 include the fully-automated synthesis step of Full-automatic chemiluminescence immunoassay analysis meter:
Step 1) add the sample to be measured after 20 μ L calibration objects or quality-control product or 1:20 dilution in detector tube;
Step 2) add No. 1, the Anti-SmIgG reagent of 50 μ L to step 1) in described detector tube, after mixing, 37 ± 0.5 DEG C of incubation 10min;
Step 3) add the Anti-SmIgG Magneto separate reagent of 50 μ L to step 2) in described detector tube, after mixing, 37 ± 0.5 DEG C of incubation 5min, carry out Magneto separate, remove supernatant;
Step 4) add the cleaning fluid of 300 μ L in detector tube, mixing, carries out Magneto separate and removes supernatant;
Step 5) repeat step 4) twice;
Step 6) add No. 2,150 μ LAnti-SmIgG reagent in detector tube, after mixing, 37 ± 0.5 DEG C of incubation 10min, carry out Magneto separate and remove supernatant;
Step 7) add the cleaning fluid of 300 μ L in detector tube, mixing, carries out Magneto separate and removes supernatant;
Step 8) repeat step 7) twice;
Step 9) add the chemical luminous substrate of 200 μ L in detector tube, mixing, detect luminous intensity.
CN201510783185.2A 2015-11-16 2015-11-16 Kit for quantitative detection of anti-Sm antibody IgG by using magnetic particle chemiluminescence, and preparation method and detection method thereof Pending CN105467130A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510783185.2A CN105467130A (en) 2015-11-16 2015-11-16 Kit for quantitative detection of anti-Sm antibody IgG by using magnetic particle chemiluminescence, and preparation method and detection method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510783185.2A CN105467130A (en) 2015-11-16 2015-11-16 Kit for quantitative detection of anti-Sm antibody IgG by using magnetic particle chemiluminescence, and preparation method and detection method thereof

Publications (1)

Publication Number Publication Date
CN105467130A true CN105467130A (en) 2016-04-06

Family

ID=55605055

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510783185.2A Pending CN105467130A (en) 2015-11-16 2015-11-16 Kit for quantitative detection of anti-Sm antibody IgG by using magnetic particle chemiluminescence, and preparation method and detection method thereof

Country Status (1)

Country Link
CN (1) CN105467130A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105929165A (en) * 2016-04-20 2016-09-07 北京中航赛维生物科技有限公司 Magnetic particle-based quantitative chemiluminescent assay kit for anti-SLA/LP antibody IgG, and preparation and detection methods thereof
CN106645711A (en) * 2016-06-30 2017-05-10 深圳市亚辉龙生物科技股份有限公司 Anti-Sm antibody IgG determining kit (chemiluminiscence method) and preparation method thereof
CN108037285A (en) * 2017-11-29 2018-05-15 北京美联泰科生物技术有限公司 A kind of magnetic microparticle chemiluminescence quantitatively detects kit of UCHL-1 and preparation method thereof
CN108226498A (en) * 2018-01-09 2018-06-29 郑州安图生物工程股份有限公司 A kind of detection alpha-fetoprotein variant AFP-(L1+L2)Kit

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008057366A2 (en) * 2006-11-01 2008-05-15 Beckman Coulter, Inc. Binding surfaces for affinity assays
CN101377514A (en) * 2008-03-25 2009-03-04 北京科美东雅生物技术有限公司 Insulin autoantibody chemiluminescence immune analysis determination reagent kit and preparing method thereof
CN102147408A (en) * 2010-12-31 2011-08-10 深圳市亚辉龙生物科技有限公司 Method for testing anti-SmD1 antibody IgG and reagent device
CN103833859A (en) * 2014-03-29 2014-06-04 陈仁奋 Novel Smith chimeric peptide antigen and application thereof in experimental diagnosis
CN103901203A (en) * 2014-04-11 2014-07-02 苏州浩欧博生物医药有限公司 Chemiluminescence quantitative detection kit for procalcitonin, and preparation method and detection method thereof
CN104459107A (en) * 2014-04-05 2015-03-25 北京中航赛维生物科技有限公司 Quantitative measurement kit for myeloperoxidase antibody (MPO-Ab) and detection method thereof
CN104614535A (en) * 2015-02-10 2015-05-13 深圳市新产业生物医学工程股份有限公司 Thyroid microsomal antibody detection reagent kit as well as preparation method and application thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008057366A2 (en) * 2006-11-01 2008-05-15 Beckman Coulter, Inc. Binding surfaces for affinity assays
CN101377514A (en) * 2008-03-25 2009-03-04 北京科美东雅生物技术有限公司 Insulin autoantibody chemiluminescence immune analysis determination reagent kit and preparing method thereof
CN102147408A (en) * 2010-12-31 2011-08-10 深圳市亚辉龙生物科技有限公司 Method for testing anti-SmD1 antibody IgG and reagent device
CN103833859A (en) * 2014-03-29 2014-06-04 陈仁奋 Novel Smith chimeric peptide antigen and application thereof in experimental diagnosis
CN104459107A (en) * 2014-04-05 2015-03-25 北京中航赛维生物科技有限公司 Quantitative measurement kit for myeloperoxidase antibody (MPO-Ab) and detection method thereof
CN103901203A (en) * 2014-04-11 2014-07-02 苏州浩欧博生物医药有限公司 Chemiluminescence quantitative detection kit for procalcitonin, and preparation method and detection method thereof
CN104614535A (en) * 2015-02-10 2015-05-13 深圳市新产业生物医学工程股份有限公司 Thyroid microsomal antibody detection reagent kit as well as preparation method and application thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105929165A (en) * 2016-04-20 2016-09-07 北京中航赛维生物科技有限公司 Magnetic particle-based quantitative chemiluminescent assay kit for anti-SLA/LP antibody IgG, and preparation and detection methods thereof
CN106645711A (en) * 2016-06-30 2017-05-10 深圳市亚辉龙生物科技股份有限公司 Anti-Sm antibody IgG determining kit (chemiluminiscence method) and preparation method thereof
CN108037285A (en) * 2017-11-29 2018-05-15 北京美联泰科生物技术有限公司 A kind of magnetic microparticle chemiluminescence quantitatively detects kit of UCHL-1 and preparation method thereof
CN108226498A (en) * 2018-01-09 2018-06-29 郑州安图生物工程股份有限公司 A kind of detection alpha-fetoprotein variant AFP-(L1+L2)Kit

Similar Documents

Publication Publication Date Title
CN105352946A (en) Kit for magnetic particle chemiluminescent quantitative detection of anti-SS-B antibody IgG and its preparation method and detection method
CN105466913A (en) Kit for quantitative detection of anti-Jo-1 antibody IgG by using magnetic particle chemiluminescence, and preparation method and detection method thereof
CN103901203B (en) Chemical luminescent analysis reagent kid of a kind of Procalcitonin and preparation method thereof and detection method
CN105445456A (en) Kit for quantitatively detecting anti-SS-A antibody IgG by utilizing magnetic particle chemiluminescence, preparation method and detection method thereof
CN102998467B (en) β human chorionic gonadotrophin magnetic microparticle chemiluminescence immune quantitative detection reagent box and preparation method thereof
CN105954267A (en) Magnetic particle-based quantitative chemiluminescent assay kit for anti-histone antibody IgG, and preparation and detection methods thereof
US8956823B2 (en) Anti-antibody reagent
CN102507918B (en) Kit for determining anti-cyclic citrullinated peptide (Anti-CCP) antibody
CN105467130A (en) Kit for quantitative detection of anti-Sm antibody IgG by using magnetic particle chemiluminescence, and preparation method and detection method thereof
CN105203748A (en) Quantitative detection kit for full-measuring-range C reaction protein
CN105929156A (en) Magnetic particle-based quantitative chemiluminescent assay kit for anti-double-stranded DNA antibody IgG, and preparation and detection methods thereof
CN103837674A (en) Method for detecting specific IgE antibody, kit used in method and preparation and using methods for kit
CN103364568A (en) Laminin nano-magnetic particle chemiluminescent immunity quantitative detection kit and preparation method thereof
CN105259344A (en) Kit for quantitative detection of Scl-70 resisting antibody IgG through chemiluminiscence of magnetic particles and preparing method and detection method of kit
CN105301235A (en) Kit used for quantitative determination anti-nucleosome antibody Ig G via magnetic micro particle chemiluminiscence, and preparation method and detection method thereof
CN107389946A (en) Sugar antigen CA19 9 determines kit and its detection method
Song et al. Rapid and quantitative detection of SARS-CoV-2 IgG antibody in serum using optofluidic point-of-care testing fluorescence biosensor
CN104237513A (en) Thyroid peroxidase antibody magnetic-particle chemiluminescence immune quantitative testing kit
CN105929166A (en) Magnetic particle-based quantitative chemiluminescent assay kit for anti-LKM-1 antibody IgG, and preparation and detection methods thereof
CN105277717A (en) Magnetic particle separation and chemiluminescence immunoassay method of thyroglobulin
CN107957495A (en) A kind of CK-MB detection kits and its application method
CN107677808A (en) A kind of immue quantitative detection reagent box of thyroglobulin and preparation method thereof and detection method
CN107831314A (en) A kind of N middle-ends BGP chemiluminescence detection kit and preparation method thereof
CN105300965A (en) Kit for quantitatively determining anti-nRNP/Sm antibody IgG by using magnetic particle chemiluminescence and detection method
CN105181694A (en) Carcino-embryonic antigen latex enhanced immunoturbidimetric kit and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160406